Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, which is the generic version of Forest's Namenda ® Tablets. Mylan received final ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil ...

A long-established Alzheimer's drug can help people with a disorder that causes them to compulsively pull at their hair or pick at their skin, a new clinical trial has concluded. Memantine ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

(Reuters) - Actavis PLC and six generic drugmakers have been hit with a class action accusing them of conspiring to delay the launch of generic versions of Actavis' Alzheimer's drug Namenda. Sign up ...

Allergan plc (NYSE: AGN), today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into a settlement ...

CHICAGO--(BUSINESS WIRE)--If You Purchased, Paid for, or Provided Reimbursement for the Alzheimer’s Disease Drug Namenda XR or Namenda IR and its AB-rated generic equivalents, between April 14, 2010 ...

New research at the University of Chicago Medicine has found that a drug commonly used to treat symptoms of Alzheimer’s disease effectively reduced symptoms of adults who experience compulsive ...

Memantine, a drug typically used to treat symptoms of Alzheimer's disease (AD), is linked to a significant reduction in symptoms of trichotillomania and skin-picking disorder, new research shows.